EIF3G and blood platelet disease: Additionally, eukaryotic translation initiation factor 3 subunit G (Eif3g) that has an essential role in the Wnt signalling pathway and myosin heavy chain 10 (MYH10) that acts as a biomarker in platelet disorders (Antony‐Debre et al., 2012; Bluteau et al., 2012) are upregulated on BM‐MSCs treated with MV4‐11 sEVs (Figure 3d).